Cullinan Therapeutics Inc (CGEM)
Stock-Based Compensation
$8.45M
Quarterly · Period ending: · USD
CGEM Stock-Based Compensation
Latest reported$8.45Mperiod ending
Latest reported$8.45Mperiod ending
CGEM Quarterly Stock-Based Comp ($8.50K → $8.45M)
Quarterly stock-based compensation
High-resolution chart · PNG
CGEM stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 8,447,000 | |
| 7,616,000 | |
| 7,312,000 | |
| 9,467,000 | |
| 9,887,000 | |
| 9,374,000 | |
| 9,634,000 | |
| 9,430,000 | |
| 10,533,000 | |
| 8,227,000 | |
| 7,519,000 | |
| 7,740,000 | |
| 7,920,000 | |
| 7,259,000 | |
| 7,513,000 | |
| 5,271,000 | |
| 8,608,000 | |
| 6,565,000 | |
| 12,145,000 | |
| 4,557,000 | |
| 4,165,000 | |
| 3,508,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 8,500 | |
| 8,500 |